麻豆传媒

In a phase III study of adults with pre-diabetes and obesity or overweight, tirzepatide (Zepbound) reduced the risk of over a 3-year period, Eli Lilly announced.

In related news, real-world data on patients with obesity but without diabetes found in tirzepatide versus semaglutide (Wegovy) users. (eClinicalMedicine)

Researchers in Health Affairs estimated that Medicare would increase annual spending by $3 billion to $6 billion.

Severe menopausal symptoms were associated with a 74% higher odds of in postmenopausal women. (Menopause)

A for adolescents with type 1 diabetes improved diabetes distress and self-management but had no impact on HbA1c levels. (JAMA Network Open)

Tandem Diabetes Care said an to address a problem with its t:slim X2 insulin pump where the battery rapidly drained.

Higher in males were tied to increased waist circumference, waist-to-hip ratio, fat mass, and decreased lean body and muscle mass. As for females, higher renin -- but not aldosterone -- was linked with increased waist circumference, waist-to-hip ratio, and cardiac adiposity. (Journal of Clinical Endocrinology & Metabolism)

Patients wondering whether their for weight loss can use a tool offered by healthcare start-up Ro to find out. (CNBC)

Capsules containing an investigational γ-aminobutyric acid (GABA) analogue significantly in a phase III trial of Chinese patients with diabetic peripheral neuropathic pain. (JAMA Network Open)

High levels of the lipid metabolites HDL, 3-hydroxybutyrate, and sphingomyelins were linked with a decreased risk of in females. (Scientific Reports)

U.S. healthcare providers are receiving regarding their promotion of compounded versions of tirzepatide. (Reuters)

Real-world data added more evidence for the continued reliability of in the follow-up of differentiated thyroid cancer patients. (Journal of Clinical Endocrinology & Metabolism)

Comment